SEATTLE, Aug. 27, 2012 – Since its opening in 2008, the Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment (the Ivy Center) at Swedish Medical Center's Neuroscience Institute has led the expansion drive of major research projects and expanded treatment options for patients living with brain cancer in the Pacific Northwest and throughout the world. The Ivy Center was founded in 2008 to create a world-class treatment and research facility focused on delivering excellent patient care and advancing progress toward more effective treatments for brain cancer.
Do you or someone you know shake when raising a glass of water to drink or have problems writing a check at the grocery store?
If so, essential tremor may be the cause. Essential Tremor (ET) is the most common movement disorder and those suffering from it experience uncontrolled movement , usually of the hands and arms. Over 10 million Americans are diagnosed, yet many people have never heard of it. Some assume shaking is just a sign of aging or they fear they may have Parkinson’s disease. ET differs from Parkinson's in many ways, one being ET is an "action" tremor (more pronounced when trying to complete a task) where a person with Parkinson's has tremors more often at rest and the shaking may actually lessen during activity.
Essential Tremor is caused by overactive cells in the area of the brain called the thalamus. The thalamus is about the size of a walnut and within the brain there are two of them. If there are overactive cells in the right thalamus, the person will have signs of tremor on the left side and vice versa. Some patients suffer from tremor on both sides.
It is important to know Essential Tremor is a treatable condition.
There are three common methods of treatment:
SEATTLE, Feb. 7, 2012 – Since diagnosing and managing cerebrovascular disorders can require a complex assortment of specialty evaluations and testing, Swedish Neuroscience Institute (SNI) recently opened a new Cerebrovascular Center on the first floor of James Tower at the Cherry Hill campus (550 17th Ave., Suite 110, Seattle).
SNI used patient-focused convenience as the foundation for designing the new facility, which opened Dec. 19, 2011.
“In this one location, SNI has consolidated its existing advanced diagnostics and interventional therapeutics, as well as the newest generation of technology,” said David Newell, M.D., cerebrovascular neurosurgeon and chief of Neuroscience. “The center also features the expertise of a care team that includes cerebrovascular neurosurgeons, vascular neurologists, neuroendovascular and radiosurgical specialists, neuroradiologists, neurohospitalists, and advanced practitioners who are trained to evaluate and treat cerebrovascular disorders.”
The facility also includes a Stroke Clinic.
A comprehensive menu of procedures
In addition to advanced diagnostics, the center offers ...
In September, I co-authored this cover article in the Journal of Neurosurgery on the results of a study using ultrasound for the treatment of brain hemorrhage. The study involved 33 patients with spontaneous intracerebral hemorrhage who were screened for inclusion in a SNI clinical study known as “SLEUTH” (Safety of Lysis with Ultrasound in the Treatment of Intracerebral and Intraventricular Hemorrhage). You can the abstract and full text of the article or see background information on the study, and watch a related video on WebMD.
David Newell, M.D., neurosurgeon and co-executive director of the Swedish Neuroscience Institute (SNI), co-authored the cover article in the September Journal of Neurosurgery on the results of a study using ultrasound for the treatment of brain hemorrhage. The study involved 33 patients with spontaneous intracerebral hemorrhage who were screened for inclusion in a SNI clinical study known as “SLEUTH” (Safety of Lysis with Ultrasound in the Treatment of Intracerebral and Intraventricular Hemorrhage). Read the abstract and full text of the article. Read background information on the study. Watch a related video on WebMD.